Thomas Andersson
Corporate Officer/Principal chez KAROLINSKA DEVELOPMENT AB
Provenance du réseau au premier degré de Thomas Andersson
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Financial Conglomerates | 12 | |
Lund University Bioscience AB
 Lund University Bioscience AB Investment ManagersFinance Lund University Bioscience AB (LU Bio) is an investment firm located in Lund, Sweden. In May 2007, LU Bio was founded by the parent firm, Lund University Development AB. They specialize in early-stage investments within the life sciences segment. Lund University was founded by the Swedish government in 1666. The university has three main research areas: medicine and pharmaceuticals, globally sustainable societal development, and the life sciences.
6
| Extinct | Investment Managers | 6 |
Kongsberg Beam Technology AS
 Kongsberg Beam Technology AS Miscellaneous Commercial ServicesCommercial Services Kongsberg Beam Technology AS develops and provides solutions for precise therapeutic radiation. The company was founded on August 2, 2005 and is headquartered in Kongsberg, Norway.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
| Public Company | Pharmaceuticals: Major | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Thomas Andersson via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| CELGENE | Biotechnology | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SINO BIOPHARMACEUTICAL LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal Chairman Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree | |
Takeda Corp.
 Takeda Corp. Pharmaceuticals: MajorHealth Technology Takeda Corp. manufactures and distributes pharmaceutical products. The company is headquartered in Tokyo, Japan | Pharmaceuticals: Major | Corporate Officer/Principal | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Stockholm School of Economics | College/University | Masters Business Admin Masters Business Admin | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Private Equity Investor Chief Executive Officer Director of Finance/CFO | |
| SCIBASE HOLDING AB (PUBL) | Medical Specialties | Director/Board Member Director/Board Member | |
| INDEX PHARMACEUTICALS HOLDING AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
Arexis AB
 Arexis AB Pharmaceuticals: MajorHealth Technology Arexis AB develops and manufactures pharmaceutical products. Its products are used for molecular dissection of metabolic and inflammatory diseases. The company was founded in 1999 and is headquartered in Goteborg, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Director/Board Member | |
| University of Lund | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
| PROMIMIC AB | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| POWERCELL SWEDEN AB | Alternative Power Generation | Director/Board Member | |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
WC Likvid AB
 WC Likvid AB Real Estate DevelopmentFinance WC Likvid AB owns and manages movable and immovable property. The company was founded by Tadeusz Wojciech Wieloch on June 5, 2009 and is headquartered in Staffanstorp, Sweden. | Real Estate Development | President Corporate Officer/Principal Chairman | |
| Pfizer NV/SA | Corporate Officer/Principal | ||
S:t Eriks Ögonsjukhus AB
 S:t Eriks Ögonsjukhus AB Hospital/Nursing ManagementHealth Services S:t Eriks Ögonsjukhus AB operates eye hospitals. It specializes in corneal transplant; medical and surgical treatments of retina; oculoplastic surgery, ophthalmic oncology and pathology services; and medical contact lens service for infants and children. The company is headquartered in Stockholm, Sweden. | Hospital/Nursing Management | Director/Board Member | |
| CANTARGIA AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
| BIOVICA INTERNATIONAL AB | Biotechnology | Director/Board Member | |
| Mesothelioma Applied Research Foundation, Inc. | Director/Board Member | ||
InDex Diagnostics AB
 InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Pharmaceuticals: Major | Director/Board Member Chairman | |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| OSSDSIGN AB | Medical Specialties | Director/Board Member Director/Board Member | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
| KD Incentive AB | Director/Board Member Director/Board Member | ||
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Chairman Chief Executive Officer | |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Chairman Director/Board Member | |
Monocl AB
 Monocl AB Internet Software/ServicesTechnology Services Monocl AB develops cloud-based stakeholder platform. Its areas include business development, valuation, and communication. The company was founded by Björn Carlsson and Tobias Thornblad in 2011 and is headquartered in Gothenburg, Sweden. | Internet Software/Services | Director/Board Member | |
| Scibase AB | Director/Board Member Director/Board Member | ||
| Airsonett Holding AB | Corporate Officer/Principal Director/Board Member | ||
Svenska Vaccinfabriken Produktion AB
 Svenska Vaccinfabriken Produktion AB BiotechnologyHealth Technology Svenska Vaccinfabriken Produktion AB develops vaccines and immunotherapies to prevent and treat life-threatening diseases. The company is based in Stockholm, Sweden. The Swedish company was founded by Matti Sällberg, Margaret Chen, Jens Bäck, Lars Frelin. Richard Bethell has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
Softhale NV
 Softhale NV Miscellaneous Commercial ServicesCommercial Services Softhale NV engages in manufacturing medical, clinical and pharmaceutical equipment. The company was founded by Jurgen Rawert and Frank Bartels and is headquartered in Diepenbeek, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Healthcom GmbH | Corporate Officer/Principal | ||
Perma Ventures AB
 Perma Ventures AB Investment ManagersFinance Perma Ventures AB provides financial advisory services. The private company is based in Stockholm, Sweden. | Investment Managers | Director/Board Member | |
Stiftelsen Bota Cancer
 Stiftelsen Bota Cancer Investment Trusts/Mutual FundsMiscellaneous Stiftelsen Bota Cancer operates a cancer foundation. The private company is based in Gothenburg, Sweden. | Investment Trusts/Mutual Funds | Director/Board Member | |
Anian AB
 Anian AB Miscellaneous Commercial ServicesCommercial Services Anian AB provides corporate consulting and securities brokerage services. The private company is based in Gronviksvagen, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
| MedTech Europe | Director/Board Member | ||
| RE:NEWCELL AB | Textiles | Director/Board Member | |
| COCIR | Director/Board Member | ||
| E-Hälsomyndigheten | Director/Board Member | ||
VOC Diagnostics AB
 VOC Diagnostics AB Medical/Nursing ServicesHealth Services VOC Diagnostics AB is a cancer diagnostics firm focusing on detection of ovarian cancer as a first indication. The company was founded by György Horvath in 2017 and is headquartered in Solna, Sweden. | Medical/Nursing Services | Chairman Chief Executive Officer | |
AnaCardio AB
 AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
invoX Pharma Ltd.
 invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., invoX Pharma Ltd. is a British biopharmaceutical company. The company is based in Kingston-upon-Thames, UK. The company was founded in 2021. Benjamin Toogood has been the CEO of the company since 2023. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Investment Officer |
Statistiques
Internationale
| Suède | 39 |
| Belgique | 5 |
| Etats-Unis | 4 |
| Hong Kong | 2 |
| Japon | 2 |
Sectorielle
| Health Technology | 25 |
| Commercial Services | 5 |
| Consumer Services | 4 |
| Finance | 4 |
| Technology Services | 3 |
Opérationnelle
| Director/Board Member | 176 |
| Corporate Officer/Principal | 50 |
| Chief Executive Officer | 28 |
| Chairman | 27 |
| Director of Finance/CFO | 23 |
Relations les plus connectées
- Bourse
- Insiders
- Thomas Andersson
- Connexions Sociétés